FMP

FMP

Enter

PYPD - PolyPid Ltd.

Discounted Cash Flow Model Levered of PolyPid Ltd.(PYPD), PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products ba

photo-url-https://financialmodelingprep.com/image-stock/PYPD.png

PolyPid Ltd.

PYPD

NASDAQ

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

4.4 USD

-0.09 (-2.05%)

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep